PRESS RELEASE published on 01/22/2024 at 08:30, 7 months 29 days ago Abivax: Perspectives stratégiques d’Abivax pour 2024 et principales étapes au cours des 12 prochains mois Abivax annonce ses perspectives stratégiques pour 2024 et les principales étapes des 12 prochains mois, y compris la publication des premiers résultats des essais d'induction du programme pivot ABTECT de phase 3 Abivax Obefazimod Stratégique Perspectives Étapes Clés
PRESS RELEASE published on 10/30/2023 at 18:00, 10 months 20 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.23.
PRESS RELEASE published on 10/24/2023 at 22:05, 10 months 26 days ago Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market
PRESS RELEASE published on 10/24/2023 at 22:05, 10 months 26 days ago Abivax annonce la réalisation de son introduction en bourse sur le Nasdaq Global Market
PRESS RELEASE published on 10/20/2023 at 19:30, 10 months 30 days ago Abivax annonce la mise à disposition d’un prospectus dans le cadre de son offre au public d’actions ordinaires sous la forme d’ADS à l’occasion de son introduction en bourse sur le Nasdaq Global Marke
PRESS RELEASE published on 10/20/2023 at 16:00, 10 months 30 days ago Abivax Announces Trading Resumption of its Ordinary Shares on Euronext Paris
PRESS RELEASE published on 10/20/2023 at 15:45, 10 months 30 days ago Abivax announces trading resumption of its ordinary shares on Euronext Paris
PRESS RELEASE published on 10/20/2023 at 15:45, 10 months 30 days ago Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
PRESS RELEASE published on 10/20/2023 at 15:00, 10 months 30 days ago Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market
PRESS RELEASE published on 10/20/2023 at 15:00, 10 months 30 days ago Abivax annonce la fixation du prix de son introduction en bourse sur le Nasdaq Global Market
Published on 09/20/2024 at 14:30, 20 minutes ago Focus Universal Inc. Announces Listing Transfer to Nasdaq Capital Market
Published on 09/20/2024 at 14:00, 50 minutes ago Scepter Files Form 10 with SEC Paving the Way for Strategic Growth
Published on 09/20/2024 at 14:00, 50 minutes ago Tectonic Metals Announces Results Of 2024 Annual General Meeting
Published on 09/20/2024 at 13:00, 1 hour 50 minutes ago Aston Bay and American West Metals Thick High-Grade Copper in Deep Drilling at the Storm Project, Nunavut, Canada
Published on 09/20/2024 at 09:05, 5 hours 45 minutes ago Nano One Closes on $5 Million Sale of Vacant Land
Published on 09/20/2024 at 14:05, 44 minutes ago The NAGA Group: Research update from NuWays available – “BUY” recommendation confirmed and price target raised to EUR 1.40
Published on 09/20/2024 at 13:00, 1 hour 49 minutes ago Le salon de l’eau, de l’énergie, de la technologie et de l’environnement (WETEX) 2024 présente les tendances d’avant-garde en matière de santé et de sécurité à domicile et sur le lieu de travail
Published on 09/20/2024 at 11:44, 3 hours 5 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 09/20/2024 at 11:20, 3 hours 29 minutes ago Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Published on 09/20/2024 at 11:14, 3 hours 35 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: RBI signs agreement on the sale of Priorbank JSC to Soven 1 Holding Limited
Published on 09/20/2024 at 08:45, 6 hours 5 minutes ago BAIKOWSKI : Rapport financier semestriel 2024
Published on 09/20/2024 at 08:00, 6 hours 50 minutes ago MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium